Kaavya Narasimhalu
National Neuroscience Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kaavya Narasimhalu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:11 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05763862 · Genotype Guided Antiplatelet Therapy In Ischemic StrokeNational Neuroscience Institute · active not recruiting · Ischemic Stroke, Transient Ischemic Attack · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:11 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- 91 citationsRCR 3.4
- A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease.Acta Neurol Scand · 201054 citationsRCR 1.8
- Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population.Am J Alzheimers Dis Other Demen · 201340 citationsRCR 1.7
- B-vitamin supplementation on mitigating post-stroke cognition and neuropsychiatric sequelae: A randomized controlled trial.Int J Stroke · 202310 citationsRCR 1.7
- Predictors of post stroke cognitive impairment: VITATOPS cognition substudy.J Stroke Cerebrovasc Dis · 202410 citationsRCR 2.6